Skip to main content
Erschienen in: Deutsche Dermatologie 12/2022

01.12.2022 | Rosazea | Fortbildung

Rosazea

Individuelle Therapie und Hautpflege

verfasst von: Dr. med. Dr. rer. biol. hum. Benjamin Clanner-Engelshofen

Erschienen in: Deutsche Dermatologie | Ausgabe 12/2022

Einloggen, um Zugang zu erhalten

Auszug

Die Volkskrankheit Rosazea ist eine chronisch-entzündliche Hauterkrankung, die meist das Gesicht betrifft. Wichtig neben einer individuellen Therapie sind die Vermeidung von Triggerfaktoren sowie eine adäquate Hautpflege und Sonnenschutz.
Literatur
1.
Zurück zum Zitat Spoendlin J et al. A study on the epidemiology of rosacea in the U.K. Br J Dermatol 2012; 167: 598-605. Spoendlin J et al. A study on the epidemiology of rosacea in the U.K. Br J Dermatol 2012; 167: 598-605.
2.
Zurück zum Zitat Kyriakis KP et al. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005; 53: 918-9 Kyriakis KP et al. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005; 53: 918-9
3.
Zurück zum Zitat Gether L et al. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol 2018; 179: 282-9 Gether L et al. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol 2018; 179: 282-9
4.
Zurück zum Zitat Reinholz M, Clanner-Engelshofen B. S2k-Leitlinie Rosazea. AWMF-Reg.-Nr. 013-065, 2022 Reinholz M, Clanner-Engelshofen B. S2k-Leitlinie Rosazea. AWMF-Reg.-Nr. 013-065, 2022
5.
Zurück zum Zitat Schaller M et al. Rosacea Management: Update on general measures and topical treatment options. J Dtsch Dermatol Ges 2016; 14 Suppl 6: 17-27 Schaller M et al. Rosacea Management: Update on general measures and topical treatment options. J Dtsch Dermatol Ges 2016; 14 Suppl 6: 17-27
6.
Zurück zum Zitat Schaller M et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol 2020; 182: 1269-76 Schaller M et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. Br J Dermatol 2020; 182: 1269-76
7.
Zurück zum Zitat Reinholz M et al. Pathogenese und Klinik der Rosazea als Schlüssel für eine symptomorientierte Therapie. J Dtsch Dermatol Ges 2016; 14 Suppl 6: 4-16 Reinholz M et al. Pathogenese und Klinik der Rosazea als Schlüssel für eine symptomorientierte Therapie. J Dtsch Dermatol Ges 2016; 14 Suppl 6: 4-16
8.
Zurück zum Zitat Aldrich N et al. Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins. JAMA Dermatol 2015; 151: 1213-9 Aldrich N et al. Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins. JAMA Dermatol 2015; 151: 1213-9
9.
Zurück zum Zitat van Steensel MAM et al. Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2/CARD15 polymorphism R702W. Exp Dermatol 2008; 17: 1057-8 van Steensel MAM et al. Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2/CARD15 polymorphism R702W. Exp Dermatol 2008; 17: 1057-8
10.
Zurück zum Zitat Steinhoff M et al. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol 2013; 69: S15−26 Steinhoff M et al. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol 2013; 69: S15−26
11.
Zurück zum Zitat Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol 2017; 26: 659-67 Holmes AD, Steinhoff M. Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics. Exp Dermatol 2017; 26: 659-67
12.
Zurück zum Zitat Yamasaki K, Gallo RL. Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc 2011; 15: 12-5 Yamasaki K, Gallo RL. Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc 2011; 15: 12-5
13.
Zurück zum Zitat Yamasaki K et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975-80 Yamasaki K et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975-80
14.
Zurück zum Zitat Turgut Erdemir A et al. Demodex mites in acne rosacea: reflectance confocal microscopic study. Australas J Dermatol 2017; 58: e26−30 Turgut Erdemir A et al. Demodex mites in acne rosacea: reflectance confocal microscopic study. Australas J Dermatol 2017; 58: e26−30
15.
Zurück zum Zitat Sulk M et al. Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea. J Invest Dermatol 2012; 132: 1253-62 Sulk M et al. Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea. J Invest Dermatol 2012; 132: 1253-62
16.
Zurück zum Zitat Steinhoff M et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Invest Dermatol Symp Proc 2011; 15: 2-11 Steinhoff M et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Invest Dermatol Symp Proc 2011; 15: 2-11
17.
Zurück zum Zitat Sattler EC et al. Reflectance confocal microscopy for monitoring the density of Demodex mites in patients with rosacea before and after treatment. Br J Dermatol 2015; 173: 69-75. Sattler EC et al. Reflectance confocal microscopy for monitoring the density of Demodex mites in patients with rosacea before and after treatment. Br J Dermatol 2015; 173: 69-75.
18.
Zurück zum Zitat Moore C et al. UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling. Proc Natl Acad Sci USA 2013; 110: E3225−34 Moore C et al. UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling. Proc Natl Acad Sci USA 2013; 110: E3225−34
19.
Zurück zum Zitat Jarmuda S et al. Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol 2012; 61: 1504-10 Jarmuda S et al. Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol 2012; 61: 1504-10
20.
Zurück zum Zitat Forton FMN, de Maertelaer V. Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease? J Eur Acad Dermatol Venereol 2018; 32: 1011-6 Forton FMN, de Maertelaer V. Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease? J Eur Acad Dermatol Venereol 2018; 32: 1011-6
21.
Zurück zum Zitat Forton FMN. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol 2012; 26: 19-28 Forton FMN. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol 2012; 26: 19-28
22.
Zurück zum Zitat Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol 1993; 128: 650-9 Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol 1993; 128: 650-9
23.
Zurück zum Zitat Casas C et al. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol 2012; 21: 906-10 Casas C et al. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol 2012; 21: 906-10
24.
Zurück zum Zitat Bonnar E et al. The Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28: 443-8 Bonnar E et al. The Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28: 443-8
25.
Zurück zum Zitat Williamson T et al. Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study. Am Health Drug Benefits 2018; 11: 97-106 Williamson T et al. Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study. Am Health Drug Benefits 2018; 11: 97-106
26.
Zurück zum Zitat Gollnick H et al. Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 2010; 8: 505-15 Gollnick H et al. Systemic isotretinoin in the treatment of rosacea - doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 2010; 8: 505-15
27.
Zurück zum Zitat Schmidt JB et al. 13-cis-Retinoic acid in rosacea. Clinical and laboratory findings. Acta Derm Venereol 1984; 64: 15-21 Schmidt JB et al. 13-cis-Retinoic acid in rosacea. Clinical and laboratory findings. Acta Derm Venereol 1984; 64: 15-21
28.
Zurück zum Zitat Nikolowski J, Plewig G. Rosazea. Orale Behandlung mit 13-cis-Retinsäure. Hautarzt 1980; 31: 660-1 Nikolowski J, Plewig G. Rosazea. Orale Behandlung mit 13-cis-Retinsäure. Hautarzt 1980; 31: 660-1
29.
Zurück zum Zitat Marsden JR et al. Response of rosacea to isotretinoin. Clin Exp Dermatol 1984; 9: 484-8 Marsden JR et al. Response of rosacea to isotretinoin. Clin Exp Dermatol 1984; 9: 484-8
30.
Zurück zum Zitat Erdogan FG et al. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998; 134: 884-5 Erdogan FG et al. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998; 134: 884-5
31.
Zurück zum Zitat Hoting E et al. Treatment of rosacea with isotretinoin. Int J Dermatol 1986; 25: 660-3 Hoting E et al. Treatment of rosacea with isotretinoin. Int J Dermatol 1986; 25: 660-3
32.
Zurück zum Zitat Seite S. Thermal waters as cosmeceuticals: La Roche-Posay thermal spring water example. Clin Cosmet Investig Dermatol 2013; 6: 23-8 Seite S. Thermal waters as cosmeceuticals: La Roche-Posay thermal spring water example. Clin Cosmet Investig Dermatol 2013; 6: 23-8
33.
Zurück zum Zitat Peuvrel L et al. Evaluation of quality of life after a medical corrective make-up lesson in patients with various dermatoses. Dermatology 2012; 224: 374-80 Peuvrel L et al. Evaluation of quality of life after a medical corrective make-up lesson in patients with various dermatoses. Dermatology 2012; 224: 374-80
34.
Zurück zum Zitat Mias C et al. Protective properties of Avène Thermal Spring Water on biomechanical, ultrastructural and clinical parameters of human skin. J Eur Acad Dermatol Venereol 2020; 34 Suppl 5: 15-20 Mias C et al. Protective properties of Avène Thermal Spring Water on biomechanical, ultrastructural and clinical parameters of human skin. J Eur Acad Dermatol Venereol 2020; 34 Suppl 5: 15-20
35.
Zurück zum Zitat Karagülle MZ et al. In vitro evaluation of natural thermal mineral waters in human keratinocyte cells: a preliminary study. Int J Biometeorol 2018; 62: 1657-61 Karagülle MZ et al. In vitro evaluation of natural thermal mineral waters in human keratinocyte cells: a preliminary study. Int J Biometeorol 2018; 62: 1657-61
36.
Zurück zum Zitat Eliasse Y et al. Impact of Avène Thermal Spring Water on immune cells. J Eur Acad Dermatol Venereol 2020; 34 Suppl 5: 21-6 Eliasse Y et al. Impact of Avène Thermal Spring Water on immune cells. J Eur Acad Dermatol Venereol 2020; 34 Suppl 5: 21-6
Metadaten
Titel
Rosazea
Individuelle Therapie und Hautpflege
verfasst von
Dr. med. Dr. rer. biol. hum. Benjamin Clanner-Engelshofen
Publikationsdatum
01.12.2022
Verlag
Springer Medizin
Schlagwort
Rosazea
Erschienen in
Deutsche Dermatologie / Ausgabe 12/2022
Print ISSN: 2731-7692
Elektronische ISSN: 2731-7706
DOI
https://doi.org/10.1007/s15011-022-5670-y

Weitere Artikel der Ausgabe 12/2022

Deutsche Dermatologie 12/2022 Zur Ausgabe

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.